CFH rs379489: What Your Genotype Means
The rs379489 variant is a single nucleotide polymorphism located within the CFH gene. Research has identified this variant as having a statistical association with non-diabetic end-stage kidney disease in certain populations.
What each genotype means
Typical complement factor H
This genotype represents the most common form of this variant in many populations. Research indicates that individuals with this genotype do not carry the specific allele associated with increased risk for non-diabetic end-stage kidney disease in certain studies. This result does not rule out other genetic or environmental factors that may influence kidney health.
This is the most frequent genotype observed in many global populations.
Increased risk marker present
Carrying one copy of the T allele has been associated in some research with a higher statistical risk for non-diabetic end-stage kidney disease, particularly in African American populations. This association is based on population-level data and does not mean you will develop kidney disease. You should discuss your overall kidney health and any concerns with your healthcare provider.
This genotype is found in a significant portion of the population, with frequency varying notably by ancestry.
Elevated risk marker present
Carrying two copies of the T allele is associated with a higher statistical risk for non-diabetic end-stage kidney disease in certain studies, specifically among African American cohorts. This finding reflects a statistical trend observed in research and is not a clinical diagnosis. Please consult with a medical professional to discuss your personal health history and appropriate screening.
This genotype is less common than the C/C or C/T genotypes in many populations, with prevalence varying by ancestral background.
Understanding the Variant
The variant rs379489 is a single nucleotide polymorphism (SNP) located on chromosome 1 within the CFH gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is classified as intronic, meaning it resides within an intron—a non-coding region of the gene that is removed during the process of creating a functional protein. While intronic variants do not change the amino acid sequence of the protein directly, they can sometimes influence how genes are regulated or expressed. Scientists study these markers to understand how subtle differences in our genetic code might contribute to complex health traits or disease susceptibility over time.
The Role of the CFH Gene
The CFH gene provides the instructions for producing a protein called complement factor H. This protein is a critical component of the complement system, which is part of the body's innate immune response. The complement system acts as a defense mechanism to help destroy foreign invaders like bacteria and viruses, trigger inflammation, and clear cellular debris. Because this system is powerful, it must be tightly regulated to ensure it only targets unwanted materials and does not damage the body's own healthy cells. Complement factor H acts as a regulator, preventing the system from becoming overactive. When the function of this protein is altered, it can lead to various health conditions, particularly those involving the kidneys or the eyes.
Research and Associations
Scientific research, including studies published in journals like Nephrology Dialysis Transplantation, has investigated the link between rs379489 and kidney health. Specifically, this variant has been studied for its association with non-diabetic end-stage kidney disease (ESKD), particularly in African American populations. The evidence for this association is considered moderate, as it stems from genome-wide association studies (GWAS) that look for statistical correlations between genetic markers and specific health outcomes. It is important to note that these findings represent statistical associations rather than direct causation. Many factors, including other genetic variants, environmental influences, and lifestyle, contribute to the development of kidney disease. Because the evidence is specific to certain ancestral groups, it may not apply universally to all populations.
Interpreting Your Information
If you have received information about your rs379489 genotype, it is important to view it in the proper context. This variant is a tool for researchers to understand population-level health trends, not a diagnostic test for an individual. Having a particular genotype does not mean you will develop a specific condition, nor does it guarantee protection from one. Genetic information is only one piece of a much larger puzzle that includes your medical history, physical exams, and laboratory tests. You cannot use this information to make medical decisions or change your health habits on your own. If you have concerns about your kidney health or family history, the best course of action is to discuss these topics with a qualified healthcare provider who can interpret your results alongside your overall clinical picture.
How common is this variant?
The rs379489 variant is common, with a global minor allele frequency reported around 0.2576, though frequencies vary significantly across different ancestral groups.
Frequently asked questions
Is rs379489 a diagnostic test for kidney disease?
No, rs379489 is not a diagnostic test. It is a genetic marker associated with a statistical risk in certain populations, and it cannot be used to diagnose or predict the development of kidney disease in an individual.
What should I do if I have the T/T genotype?
The presence of a specific genotype does not require medical action. You should focus on maintaining overall kidney health through regular check-ups with your doctor and discussing any concerns about your family history or symptoms with them.
Does this variant affect everyone the same way?
No, the association between this variant and kidney disease has been primarily observed in specific populations, such as African Americans. Genetic associations often vary by ancestry and environmental context.
Where can I learn more about the CFH gene?
You can find reliable information about the CFH gene and its functions on resources like MedlinePlus Genetics, which provides plain-language summaries of genes and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs379489?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This variant in the Complement Factor H gene is associated with neovascular age-related macular degeneration (AMD) risk and influences patient response to anti-VEGF therapy.
This variant is associated with systemic complement activation levels and poor response to anti-VEGF treatment in neovascular age-related macular degeneration.
This variant is associated with reduced risk of neovascular age-related macular degeneration and improved response to anti-VEGF therapy.
This variant is associated with AMD and has been successfully targeted for allele-specific manipulation in retinal pigment epithelium cells.
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.